Stocks and Investing Stocks and Investing
Tue, May 10, 2022
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Upgraded (CLNE) to Buy and Held Target at $6 on, May 10th, 2022
[ 12:00 AM ] - WOPRAI
Reuben Garner Downgraded (BCC) to Hold on, May 10th, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (BERY) at Buy with Decreased Target to $70 on, May 10th, 2022
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (BHF) at Hold with Decreased Target to $62 on, May 10th, 2022
Mon, May 9, 2022
[ 12:00 AM ] - WOPRAI
Douglas Miehm Maintained (BHC) at Buy with Decreased Target to $21 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $300 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (BERY) at Buy with Decreased Target to $74 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (BERY) at Strong Buy with Decreased Target to $79 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Kyle White Maintained (BERY) at Strong Buy with Decreased Target to $69 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Sean Steuart Upgraded (BEP) to Strong Buy and Held Target at $41 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Sam Darkatsh Maintained (BECN) at Buy with Increased Target to $75 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Rick Bienkowski Maintained (BEAM) at Buy with Increased Target to $121 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Kurt Yinger Maintained (BCC) at Strong Buy with Increased Target to $88 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Nicholas Heymann Upgraded (SXI) to Buy on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Craig Bijou Initiated (TFX) at Hold and Held Target at $315 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Ric Prentiss Maintained (TDS) at Strong Buy with Decreased Target to $23 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Joe Goodwin Maintained (TDC) at Buy with Decreased Target to $72 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (TDC) at Buy with Decreased Target to $54 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Fein Maintained (TARA) at Strong Buy with Decreased Target to $30 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Dan Dolev Maintained (TOST) at Hold with Decreased Target to $19 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Drew Ranieri Maintained (TMCI) at Buy with Decreased Target to $26 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Ashwin Shirvaikar Maintained (TIXT) at Strong Buy with Decreased Target to $30 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Perlin Maintained (TIXT) at Buy with Decreased Target to $39 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Mcveigh Maintained (TIXT) at Hold with Decreased Target to $25 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Ramsey El-Assal Maintained (TIXT) at Buy with Decreased Target to $32 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Duffy Fischer Maintained (TSE) at Hold with Decreased Target to $53 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
David Anderson Maintained (TS) at Buy with Increased Target to $42 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Aleksey Yefremov Maintained (ALB) at Sell with Increased Target to $215 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Vincent Andrews Maintained (ALB) at Sell with Increased Target to $135 on, May 9th, 2022
[ 12:00 AM ] - WOPRAI
Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $18 on, May 9th, 2022

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $18 on, May 9th, 2022


Published on 2024-10-27 20:56:50 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $19 to $18 on, May 9th, 2022.

Tejas has made no other calls on AKYA in the last 4 months.



There is 1 other peer that has a rating on AKYA. Out of the 1 peers that are also analyzing AKYA, 0 agree with Tejas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tejas

  • David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $18 on, Friday, March 18th, 2022
Contributing Sources